Most existing robotic surgical platforms are at the early stages of evaluation, with the majority being in the preclinical to developmental and exploratory stage. A scoping review of 23 different robotic platforms from 21 companies revealed that only one multiport system is fully evaluated, while the rest are at various stages of assessment. None of the single-port systems have undergone full evaluation. The study emphasizes the importance of using the ideal framework to ensure comprehensive evaluation of emerging robotic platforms for patient safety and informed decision-making.
Review by Boal M, Di Girasole CG (…) Francis N et 5 al. in Surg Endosc
© 2023. The Author(s).